The Society’s significant investment will expand awards funding as part of a larger multifaceted initiative to protect hematology research and the care of patients (WASHINGTON, June 10, 2025) – Amid threats to funding for hematology rese...

A nearly 40% reduction in funding would devastate essential progress in hematology research and unnecessarily endanger patients living with blood disorders (WASHINGTON—June 6, 2025) – Yesterday, the Administration published details of the...

New clinical guidelines recommend direct oral anticoagulants over current standard of care in many children (WASHINGTON—May 27, 2025) The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) re...

Widely used cholesterol-lowering medications may reduce death rate of common blood cancer (WASHINGTON—April 23, 2025) — Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-low...

Children taking hydroxyurea visited emergency department less, had fewer hospital days (WASHINGTON, April 17, 2024) — Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with s...

Protein linked to inflammation and vaso-occlusive events is elevated in follicular phase of menstrual cycle in early study (WASHINGTON— April 9, 2025) — A marker linked to inflammation, C-reactive protein, may increase significantly durin...

Urging Thoughtful Reform: Prioritizing Patient Access, Innovative Research, and Hematology Progress in HHS Reorganization (WASHINGTON—March 28, 2025) – Yesterday, the Administration announced mass layoffs and wide-ranging restructuring o...

The open-access model shows that 25% of patients have 40% chance of dying within one year after transplant (WASHINGTON—March 27, 2025) — A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBM...

The changes offer increased opportunities and flexibility for researchers facing challenges in securing NIH funding in light of recent cutbacks to federal research support. (WASHINGTON—March 20, 2025) The American Society of Hematology (ASH) expande...

Expert panel’s findings refute attribution of sudden death to sickle cell trait (WASHINGTON—Jan. 30, 2025) – A systematic literature review found no evidence to support that physical exertion without rhabdomyolysis (muscle breakdo...